PlainRecalls
FDA Drug Low Class III Terminated

Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45

Reported: May 9, 2018 Initiated: April 17, 2018 #D-0710-2018

Product Description

Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45

Reason for Recall

Failed Dissolution Specification: Low dissolution outside of specifications

Details

Units Affected
2454 bottles
Distribution
Nationwide within the USA
Location
Coventry, RI

Frequently Asked Questions

What product was recalled?
Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45. Recalled by Rhodes Pharmaceuticals, L.P.. Units affected: 2454 bottles.
Why was this product recalled?
Failed Dissolution Specification: Low dissolution outside of specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on May 9, 2018. Severity: Low. Recall number: D-0710-2018.